Posts Tagged ‘medical advances’

First Single-Site Gallbladder Surgery at EJCH

A surgical team at Emory Johns Creek Hospital performed their first single-site gallbladder surgery on Friday, April 27, 2012. During this minimally invasive laparoscopic procedure, the patient’s gallbladder was removed via a single small incision in the belly button. The team removed the gallbladder using Single-Site™ instruments on a da Vinci® System. This robotic surgical system, which is widely used in complex minimally invasive surgery, allowed the surgeons to remove the gallbladder through an incision of approximately one inch. Traditional robotic surgeries require three to five small incisions.

Potential benefits of Single-Site gallbladder surgery include virtually scarless results, minimal pain, low blood loss, fast recovery, a short hospital stay and high patient satisfaction. The surgery can be performed in about one hour, with a typical hospital stay of less than 24 hours.

During the procedure, the surgeon sits at a console, viewing a 3D, high-definition image of the patient’s anatomy, and uses controls below the viewer to move the da Vinci Robot’s arms and camera. The system translates the surgeon’s hand, wrist, and finger movements in real-time into the more precise movements of the tiny instruments inside the patient. Most people who require gallbladder removal are candidates for the robotic, single-incision surgery.

Dr. Christopher Hart, of Emory Johns Creek Surgery, PC, and medical director of the Atlanta Bariatric Center, is one of a small group of surgeons in the country who have received training in Single-Site gallbladder surgery, and Emory Johns Creek Hospital is one of only two hospitals in the state to perform the procedure. To learn more about this procedure, visit emoryjohnscreek.com/robotics.

Healthy Events
Bariatric Surgery Information Seminar
The next seminars will be held July 11, 12, 17, 26, and August 1, 8, 9, 21, and 23.
Emory Johns Creek Hospital
Physicians’ Plaza, Suite 109
6335 Hospital Parkway

Resources

No Needle, No Scalpel Vasectomy – Q&A with Emory’s Dr. Hsiao

Dr. Wayland Hsiao, Emory Urology

Dr. Wayland Hsiao

When the Urology Department of Emory Healthcare started offering no-scalpel, no-needle vasectomies as part of their men’s health treatment options, our ears perked up. Obviously, as the name implies, this type of vasectomy procedure allows doctors to forego the scalpel and needle combination used in traditional vasectomies, but what is used in their place? And what are the benefits? To get our questions answered, we went straight to the source, Emory’s own Dr. Wayland Hsiao, who is one of the surgeons performing the procedure. Our questions for Dr. Hsiao (and his answers) are below:

What exactly does it mean when we say no-scalpel, no-needle vasectomy? Can you describe the procedure?

A vasectomy is a procedure in which when the outflow of sperm through the vas deferens is interrupted to stop the outflow of sperm. It is a permanent form of male contraception. The procedure has no effect on sexual function. The no-scalpel vasectomy is a technique that allows us to perform the vasectomy through a puncture. The puncture is made in the scrotum and requires no suturing or stitches.

When compared to the conventional vasectomy, the primary difference is that the vas deferens tissues and blood vessels are spread aside from the surgical site rather than cut with a knife. This is less traumatic, and results in less pain and fewer postoperative complications. To numb the patient before the vasectomy, a Madajet injector is used. This is a tool that facilitates a highly pressurized lidocaine (anesthetic) to be sprayed on and through the scrotal skin to numb the skin and the underlying vas deferens. No needle is used in this anesthetic technique.

So, in terms of how the procedure is performed, what are the biggest differences?

We are able to replace the traditional scalpel with a specially design sharp clamp, which alleviates the need for an incision. The traditional incision is replaced by a small puncture hole which seals itself after the procedure. We also replace the needle with an anesthetic spray (diffused via the Madajet injector) that is applied to the scrotal skin and the vas deferens itself.

What are the benefits to no-scalpel, no-needle vasectomy?

Good question. There are several. With the no-scalpel vasectomy, there is less bleeding. In fact, the bleeding rate decreases from being seen in about 3% of patients down to 0.3%. In other words, there is 10 times lesser chance of bleeding. The infection rate after vasectomy is also decreased with the no-scalpel, no-needle technique. Infection is seen in 1.4% of patients with a traditional approach, while we only see infections inabout 0.1% of men undergoing the no-scalpel technique.

The bladeless vasectomy procedure is also faster, because the need for suturing is eliminated because there is no incision. The hole or puncture (2-3mm) created from the procedure will close up on its own.

Are there any risks associated with this procedure? If so, what are they?

The no-scalpel, no-needle vasectomy doesn’t come with any additional risks that we don’t already see with the standard vasectomy procedure, which include the risk of hematoma (with no-scalpel, this risk is significantly lowered to less than 0.5 %) and infection. As is true with all vasectomy procedures, the procedure is not guaranteed to be 100% effective. The general post-vasectomy failure rate is less than 0.5 % (1 in 500 short term failure; 1 in 4500 long term failure).

How long does the no-scalpel, no-needle vasectomy take?

The procedure takes about 30 minutes.

What can patients expect after the no-scalpel, no-needle vasectomy?

Patients can expect to experience swelling of scrotom for 2-3 days and bruising for up to a week. They might also experience a feeling of heaviness or dragging testes for 2-3 weeks.

How long is the recovery? How soon can I have sex post-procedure?

To achieve full recovery, patients should wait approximately 2 weeks after the procedure before participating in intercourse, but men should consult with their physician for guidance here.

Related Resources:

Emory Home to Top Hospital in Atlanta, Nationally Ranked in 11 Specialties

Emory University Hospital Best in Atlanta

Besides the name Emory, what do our Cancer, Diabetes & Endocrinology, Ear Nose & Throat, Geriatrics, Gynecology, Heart & Heart Surgery, Kidney, Neurology & Neurosurgery, Ophthalmology, Psychiatry, and Urology programs have in common? According to U.S. News & World Report’s 2011 rankings of Best Hospitals, all of Emory’s above listed medical specialties are ranked amongst the top programs in the country.

U.S. News ranks top hospitals and specialty programs nationally every year. This year, they also conducted regional rankings of hospitals in 52 metro areas across the United States. In both polls, Emory was a standout. We are very pleased to announce that Emory University Hospital has been ranked as the best hospital in Atlanta, Georgia.

Emory is the only health care provider in Atlanta to have received over 10 national program specialty rankings. Aside from Emory, Children’s Healthcare of Atlanta (ranked separately in a category for Children’s Hospitals) was recognized with rankings in 9 specialties, and the Shepherd Center received 1 national program ranking. Meaning, of the 12 national hospital program rankings bestowed upon non-pediatric specific hospitals in the Atlanta area, Emory University Hospital received 11 of them.

What does this mean for you, our patients, families, and community members? It means that when you come to Emory, you get the type of patient-centered care you can’t find anywhere else in Atlanta or Georgia. It means that we continue to advance the possibilities with the latest medical research, technology, and process improvements that garner national recognition year after year. It also means that you can rest assured that as an Emory patient, you’re getting not only the level of care that’s expected by virtue of being a top national academic health care system, but the level of care expected by you, our community.

If you have any questions on the rankings, or just want to share your feedback, please feel free to use the comment field below.

Emory – 4th Largest Contributor to New Drug Discovery in U.S.

First announced in the February 10th issue of the New England Journal of Medicine, a new study has found that Emory is the fourth largest contributor to the discovery of new drugs and vaccines in the U.S. The contributors evaluated included federally funded universities, research hospitals, and federal laboratories.

The study found that public-sector research was involved in the discovery of as many as 20% of therapies approved by the Food and Drug Administration (FDA) from 1990-2007. Through studying the FDA review process, the researchers also found that public sector research institutes “tend to discover drugs that are expected to have a disproportionately important clinical effect.”

To determine impact of various research organizations, researchers for the study identified 153 FDA-approved drugs and vaccines that were discovered at least in part by public-sector research institutions during the past 40 years. The top five contributors were:

  • The National Institute of Health (NIH) (22)
  • The University of California System (11)
  • Memorial Sloan-Kettering (8)
  • Emory University (7)
  • Yale University (6)

The seven Emory products included HIV/AIDS drugs lamivudine (3TC) and emtricitabine (FTC), discovered by Emory scientists Dennis Liotta, PhD, and Raymond Schinazi, PhD, and their former colleague Woo-Baeg Choi, PhD. These two drugs are among the most commonly used and most successful HIV/AIDS drugs in the world, taken in some form by more than 94 percent of U.S. patients on therapy and by thousands more globally.

Emory University President, James Wagner, is extremely proud of the accomplishments of Emory researchers and scientists, commenting, “this study illustrates once again that our nation’s long-standing and world-leading policy of investment in research through universities and other public institutions, along with the responsible use of technology transfer, delivers a tremendous return through improved health for millions, innovative technologies, economic development and training for the next generation of innovators.”

We thank our Emory scientists making new discoveries that allow Emory Healthcare to continue to advance the possibilities in patient-centered health care and improve health in our communities.

Putting Patients First – Advancing Brain Treatment Possibilities

Brain cancer injury informationFor those of us who watched the President’s State of the Union address on Tuesday night, we were touched by a number of stories, conflicts, and hardships faced by Americans from all walks of life. Health care rhetoric aside, one story, that of James Howard from Katy, TX, was especially touching and relevant. Howard, who is only 28 years old, was diagnosed with brain cancer in March of 2010 and as we listened, we learned of his touching story and the barriers he faced in acquiring treatment. James Howard is not alone. There are many people out there like James Howard, who, without access to the latest medical treatments, wouldn’t be here.

While the debate regarding health care reform continues, what we at Emory can do is to provide access to the latest treatments to save lives like that of James Howard. And through our research and medical advances, that’s exactly what we’ve done for patients like Jennifer Giliberto, Gary Gelb, Neil Cullinan, and Donna Yancey, all of whom underwent brain surgery at Emory Healthcare.

Our neurosciences team of researchers, physicians, surgeons, and staff are dedicated to leading research and development in the world of brain injuries and cancers.

For example, Emory is one of the few places in the country offering minimally invasive neuro-endoscopic procedures for resection of deep-seated brain tumors and 3D endoscopic pituitary tumor removal. We’re also conducting groundbreaking research investigating solutions such as the use of magnetic nanoparticles for targeted imaging and therapy of brain cancer. This dedication advancing the medical possibilities is what drives everything we do, and our efforts aren’t going without recognition.

Recently, Dr. Costas Hadjipanayis, chief of neurosurgery at Emory University Hospital Midtown and assistant professor of neurosurgery at Emory, was named president of the Southeastern Brain Tumor Foundation. With a mission to “improve the quality of life for brain tumor patients and their families” through research, awareness, and support, the efforts of our team members such as Dr. Hadjipanayis and those of the Southeastern Brain Tumor Foundation allow us to continue to advance the possibilities in the treatment of brain tumors and injuries.

We honor the dedication shown by our neurosciences team and its members such as Dr. Costas Hadjipanayis, who are making strides in improving the lives of patients and families affected by brain injuries and cancers each and every day.

Why You Should Make Breast Health a Priority

breast health center

Second only to non-melanoma skin cancer, breast cancer is the most common type of cancer affecting women. In honor of National Breast Cancer Awareness Month, we invite you to take a look at our newly overhauled breast health resources online. In addition to updating all of our breast health information, we’ve also been making strides and medical advancements in how we diagnose breast cancer.

Emory is one of only three centers in the world using innovative breast imaging technology, dedicated breast CT, to gather information that would require 300 mammograms to collect. With the use of dedicated breast CT, doctors are hoping to reduce the number of false positives and make more accurate diagnoses from the technology’s ability to take over 300 pictures in just ten seconds.

Dedicated breast CT is used to help diagnose breast cancer in its early stages, when treatment is more likely to eradicate the cancer. Breast cancer death rates have dropped since the 1990s, mostly due to increased early detection and improvements in treatment. Early detection and awareness are two of our most valuable tools when it comes to fighting the battle against breast cancer.

Please remind a female friend or family member to schedule their routine breast health check-up. To schedule an appointment for breast imaging, please call: 404-778-PINK (404-778-7465)